A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
Clinical trial NCT00505037 · COMPLETED
Trial details
- NCT number
- NCT00505037
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2008-09-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.